M.D. Anderson Cancer Center
For more information, see ClinicalTrials.gov NCT00539162
The goal of this clinical research study is to evaluate a method involving a blood test, called CA-125, that may be helpful in the early detection of ovarian cancer in women who are at low risk.
Karen H. Lu, MD, Brian Slomovitz, MD, Georgia McCann, MD, Richard Moore, MD, Laura Holman, MD, Marian Williams-Brown, MD